Clinical trial NCT03137303 - References

COPD Asthma — Reducing Diagnostic Error to Improve Patient Safety in COPD and Asthma (REDEFINE Study)

Citation(s)

•   Abramson MJ, Schattner RL, Sulaiman ND, Del Colle EA, Aroni R, Thien F
  Accuracy of asthma and COPD diagnosis in Australian general practice: a mixed methods study. Prim Care Respir J. 2012 Jun;21(2):167-73. doi: 10.4104/pcrj.2011.00103.
•   Akinbami LJ, Liu X
  Chronic obstructive pulmonary disease among adults aged 18 and over in the United States, 1998-2009. NCHS Data Brief. 2011 Jun;(63):1-8.
•   Akinbami LJ, Moorman JE, Bailey C, Zahran HS, King M, Johnson CA, Liu X
  Trends in asthma prevalence, health care use, and mortality in the United States, 2001-2010. NCHS Data Brief. 2012 May;(94):1-8.
•   Armitage JN, Sibanda N, Cathcart PJ, Emberton M, van der Meulen JH
  Mortality in men admitted to hospital with acute urinary retention: database analysis. BMJ. 2007 Dec 8;335(7631):1199-202. doi: 10.1136/bmj.39377.617269.55. Epub 2007 Nov 8.
•   Ball JR, Balogh E
  Improving Diagnosis in Health Care: Highlights of a Report From the National Academies of Sciences, Engineering, and Medicine. Ann Intern Med. 2016 Jan 5;164(1):59-61. doi: 10.7326/M15-2256. Epub 2015 Sep 29. No abstract available.
•   Barr RG, Celli BR, Martinez FJ, Ries AL, Rennard SI, Reilly JJ Jr, Sciurba FC, Thomashow BM, Wise RA
  Physician and patient perceptions in COPD: the COPD Resource Network Needs Assessment Survey. Am J Med. 2005 Dec;118(12):1415. doi: 10.1016/j.amjmed.2005.07.059.
•   Bolton CE, Ionescu AA, Edwards PH, Faulkner TA, Edwards SM, Shale DJ
  Attaining a correct diagnosis of COPD in general practice. Respir Med. 2005 Apr;99(4):493-500. doi: 10.1016/j.rmed.2004.09.015. Epub 2004 Nov 11.
•   Buffels J, Degryse J, Liistro G, Decramer M
  Differential diagnosis in a primary care population with presumed airway obstruction: a real-life study. Respiration. 2012;84(1):44-54. doi: 10.1159/000332836. Epub 2011 Nov 15.
•   Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, Yates JC, Vestbo J; TORCH investigators
  Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med. 2007 Feb 22;356(8):775-89. doi: 10.1056/NEJMoa063070.
•   Caramori G, Bettoncelli G, Tosatto R, Arpinelli F, Visona G, Invernizzi G, Novelletto BF, Papi A, Adcock IM, Ciaccia A
  Underuse of spirometry by general practitioners for the diagnosis of COPD in Italy. Monaldi Arch Chest Dis. 2005 Mar;63(1):6-12. doi: 10.4081/monaldi.2005.651.
•   Centers for Disease Control and Prevention (CDC)
  Vital signs: asthma prevalence, disease characteristics, and self-management education: United States, 2001--2009. MMWR Morb Mortal Wkly Rep. 2011 May 6;60(17):547-52.
•   Chapman KR, Tashkin DP, Pye DJ
  Gender bias in the diagnosis of COPD. Chest. 2001 Jun;119(6):1691-5. doi: 10.1378/chest.119.6.1691.
•   Committee on Diagnostic Error in Health Care; Board on Health Care Services; Institute of Medicine; The National Academies of Sciences, Engineering, and Medicine; Balogh EP, Miller BT, Ball JR, editors
  Improving Diagnosis in Health Care. Washington (DC): National Academies Press (US); 2015 Dec 29. Available from http://www.ncbi.nlm.nih.gov/books/NBK338596/
•   Cooper R, Cutler J, Desvigne-Nickens P, Fortmann SP, Friedman L, Havlik R, Hogelin G, Marler J, McGovern P, Morosco G, Mosca L, Pearson T, Stamler J, Stryer D, Thom T
  Trends and disparities in coronary heart disease, stroke, and other cardiovascular diseases in the United States: findings of the national conference on cardiovascular disease prevention. Circulation. 2000 Dec 19;102(25):3137-47. doi: 10.1161/01.cir.102.25.3137.
•   Damarla M, Celli BR, Mullerova HX, Pinto-Plata VM
  Discrepancy in the use of confirmatory tests in patients hospitalized with the diagnosis of chronic obstructive pulmonary disease or congestive heart failure. Respir Care. 2006 Oct;51(10):1120-4.
•   Dransfield MT, Bailey WC
  COPD: racial disparities in susceptibility, treatment, and outcomes. Clin Chest Med. 2006 Sep;27(3):463-71, vii. doi: 10.1016/j.ccm.2006.04.005.
•   Ernst P, Gonzalez AV, Brassard P, Suissa S
  Inhaled corticosteroid use in chronic obstructive pulmonary disease and the risk of hospitalization for pneumonia. Am J Respir Crit Care Med. 2007 Jul 15;176(2):162-6. doi: 10.1164/rccm.200611-1630OC. Epub 2007 Mar 30.
•   Ferguson GT, Anzueto A, Fei R, Emmett A, Knobil K, Kalberg C
  Effect of fluticasone propionate/salmeterol (250/50 microg) or salmeterol (50 microg) on COPD exacerbations. Respir Med. 2008 Aug;102(8):1099-108. doi: 10.1016/j.rmed.2008.04.019. Epub 2008 Jul 9.
•   Foster JA, Yawn BP, Maziar A, Jenkins T, Rennard SI, Casebeer L
  Enhancing COPD management in primary care settings. MedGenMed. 2007 Jul 31;9(3):24.
•   Franks P, Clancy CM, Naumburg EH
  Sex, access, and excess. Ann Intern Med. 1995 Oct 1;123(7):548-50. doi: 10.7326/0003-4819-123-7-199510010-00012. No abstract available.
•   Ghattas C, Dai A, Gemmel DJ, Awad MH
  Over diagnosis of chronic obstructive pulmonary disease in an underserved patient population. Int J Chron Obstruct Pulmon Dis. 2013;8:545-9. doi: 10.2147/COPD.S45693. Epub 2013 Nov 12.
•   Global Initiative for Asthma
  Global strategy for asthma management and prevention. Bethesda, MD, USA: GINA;2015
•   Griffiths C, Feder G, Wedzicha J, Foster G, Livingstone A, Marlowe GS
  Feasibility of spirometry and reversibility testing for the identification of patients with chronic obstructive pulmonary disease on asthma registers in general practice. Respir Med. 1999 Dec;93(12):903-8. doi: 10.1016/s0954-6111(99)90057-4.
•   Guite HF, Dundas R, Burney PG
  Risk factors for death from asthma, chronic obstructive pulmonary disease, and cardiovascular disease after a hospital admission for asthma. Thorax. 1999 Apr;54(4):301-7. doi: 10.1136/thx.54.4.301.
•   Han MK, Kim MG, Mardon R, Renner P, Sullivan S, Diette GB, Martinez FJ
  Spirometry utilization for COPD: how do we measure up? Chest. 2007 Aug;132(2):403-9. doi: 10.1378/chest.06-2846. Epub 2007 Jun 5.
•   Han MK, Postma D, Mannino DM, Giardino ND, Buist S, Curtis JL, Martinez FJ
  Gender and chronic obstructive pulmonary disease: why it matters. Am J Respir Crit Care Med. 2007 Dec 15;176(12):1179-84. doi: 10.1164/rccm.200704-553CC. Epub 2007 Aug 2.
•   Joo MJ, Au DH, Fitzgibbon ML, Lee TA
  Inhaled corticosteroids and risk of pneumonia in newly diagnosed COPD. Respir Med. 2010 Feb;104(2):246-52. doi: 10.1016/j.rmed.2009.10.002. Epub 2009 Oct 30.
•   Kaminsky DA, Marcy TW, Bachand M, Irvin CG
  Knowledge and use of office spirometry for the detection of chronic obstructive pulmonary disease by primary care physicians. Respir Care. 2005 Dec;50(12):1639-48.
•   Kardos P, Wencker M, Glaab T, Vogelmeier C
  Impact of salmeterol/fluticasone propionate versus salmeterol on exacerbations in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2007 Jan 15;175(2):144-9. doi: 10.1164/rccm.200602-244OC. Epub 2006 Oct 19.
•   Khullar D, Jha AK, Jena AB
  Reducing Diagnostic Errors--Why Now? N Engl J Med. 2015 Dec 24;373(26):2491-3. doi: 10.1056/NEJMp1508044. Epub 2015 Sep 23. No abstract available.
•   Lee TA, Bartle B, Weiss KB
  Spirometry use in clinical practice following diagnosis of COPD. Chest. 2006 Jun;129(6):1509-15. doi: 10.1378/chest.129.6.1509.
•   Lee TA, Pickard AS, Au DH, Bartle B, Weiss KB
  Risk for death associated with medications for recently diagnosed chronic obstructive pulmonary disease. Ann Intern Med. 2008 Sep 16;149(6):380-90. doi: 10.7326/0003-4819-149-6-200809160-00004.
•   Lee TA, Weiss KB
  Fracture risk associated with inhaled corticosteroid use in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2004 Apr 1;169(7):855-9. doi: 10.1164/rccm.200307-926OC. Epub 2004 Jan 7.
•   Lusuardi M, De Benedetto F, Paggiaro P, Sanguinetti CM, Brazzola G, Ferri P, Donner CF
  A randomized controlled trial on office spirometry in asthma and COPD in standard general practice: data from spirometry in Asthma and COPD: a comparative evaluation Italian study. Chest. 2006 Apr;129(4):844-52. doi: 10.1378/chest.129.4.844.
•   Macie C, Wooldrage K, Manfreda J, Anthonisen N
  Cardiovascular morbidity and the use of inhaled bronchodilators. Int J Chron Obstruct Pulmon Dis. 2008;3(1):163-9. doi: 10.2147/copd.s1516.
•   Mapel DW, Picchi MA, Hurley JS, Frost FJ, Petersen HV, Mapel VM, Coultas DB
  Utilization in COPD: patient characteristics and diagnostic evaluation. Chest. 2000 May;117(5 Suppl 2):346S-53S. doi: 10.1378/chest.117.5_suppl_2.346s.
•   Martin-Merino E, Garcia-Rodriguez LA, Masso-Gonzalez EL, Roehrborn CG
  Do oral antimuscarinic drugs carry an increased risk of acute urinary retention? J Urol. 2009 Oct;182(4):1442-8. doi: 10.1016/j.juro.2009.06.051. Epub 2009 Aug 15.
•   McKeever T, Harrison TW, Hubbard R, Shaw D
  Inhaled corticosteroids and the risk of pneumonia in people with asthma: a case-control study. Chest. 2013 Dec;144(6):1788-1794. doi: 10.1378/chest.13-0871.
•   Melbye H, Drivenes E, Dalbak LG, Leinan T, Hoegh-Henrichsen S, Ostrem A
  Asthma, chronic obstructive pulmonary disease, or both? Diagnostic labeling and spirometry in primary care patients aged 40 years or more. Int J Chron Obstruct Pulmon Dis. 2011;6:597-603. doi: 10.2147/COPD.S25955. Epub 2011 Nov 17.
•   Mensah GA, Mokdad AH, Ford ES, Greenlund KJ, Croft JB
  State of disparities in cardiovascular health in the United States. Circulation. 2005 Mar 15;111(10):1233-41. doi: 10.1161/01.CIR.0000158136.76824.04.
•   Miravitlles M, de la Roza C, Naberan K, Lamban M, Gobartt E, Martin A
  Use of spirometry and patterns of prescribing in COPD in primary care. Respir Med. 2007 Aug;101(8):1753-60. doi: 10.1016/j.rmed.2007.02.019. Epub 2007 Apr 19.
•   Morbidity & Mortality: 2012 Chart Book on Cardiovascular, Lung, and Blood Diseases
  In: National Heart Lung and Blood Institute, ed2012
•   Mularski RA, Asch SM, Shrank WH, Kerr EA, Setodji CM, Adams JL, Keesey J, McGlynn EA
  The quality of obstructive lung disease care for adults in the United States as measured by adherence to recommended processes. Chest. 2006 Dec;130(6):1844-50. doi: 10.1378/chest.130.6.1844.
•   National Asthma Education and Prevention Program
  Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma-Summary Report 2007. J Allergy Clin Immunol. 2007 Nov;120(5 Suppl):S94-138. doi: 10.1016/j.jaci.2007.09.043. Erratum In: J Allergy Clin Immunol. 2008 Jun;121(6):1330.
•   National Center for Health Statistics
  Chronic Obstructive Pulmonary Disease Among Adults Aged 18 and Over in the United States, 1998-2009. 2011
•   Nelson HS, Weiss ST, Bleecker ER, Yancey SW, Dorinsky PM; SMART Study Group
  The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest. 2006 Jan;129(1):15-26. doi: 10.1378/chest.129.1.15. Erratum In: Chest. 2006 May;129(5):1393.
•   O'Dowd LC, Fife D, Tenhave T, Panettieri RA Jr
  Attitudes of physicians toward objective measures of airway function in asthma. Am J Med. 2003 Apr 1;114(5):391-6. doi: 10.1016/s0002-9343(03)00007-x.
•   Ogale SS, Lee TA, Au DH, Boudreau DM, Sullivan SD
  Cardiovascular events associated with ipratropium bromide in COPD. Chest. 2010 Jan;137(1):13-9. doi: 10.1378/chest.08-2367. Epub 2009 Apr 10.
•   Ohar J, Fromer L, Donohue JF
  Reconsidering sex-based stereotypes of COPD. Prim Care Respir J. 2011 Dec;20(4):370-8. doi: 10.4104/pcrj.2011.00070.
•   Prieto-Centurion V, Rolle AJ, Au DH, Carson SS, Henderson AG, Lee TA, Lindenauer PK, McBurnie MA, Mularski RA, Naureckas ET, Vollmer WM, Joese BJ, Krishnan JA; CONCERT Consortium
  Multicenter study comparing case definitions used to identify patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2014 Nov 1;190(9):989-95. doi: 10.1164/rccm.201406-1166OC.
•   Qaseem A, Wilt TJ, Weinberger SE, Hanania NA, Criner G, van der Molen T, Marciniuk DD, Denberg T, Schunemann H, Wedzicha W, MacDonald R, Shekelle P; American College of Physicians; American College of Chest Physicians; American Thoracic Society; European Respiratory Society
  Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. Ann Intern Med. 2011 Aug 2;155(3):179-91. doi: 10.7326/0003-4819-155-3-201108020-00008.
•   Ringbaek T, Viskum K
  Is there any association between inhaled ipratropium and mortality in patients with COPD and asthma? Respir Med. 2003 Mar;97(3):264-72. doi: 10.1053/rmed.2003.1423.
•   Sichletidis L, Chloros D, Spyratos D, Chatzidimitriou N, Chatziiliadis P, Protopappas N, Charalambidou O, Pelagidou D, Zarvalis E, Patakas D
  The validity of the diagnosis of chronic obstructive pulmonary disease in general practice. Prim Care Respir J. 2007 Apr;16(2):82-8. doi: 10.3132/pcrj.2007.00016.
•   Singh H, Graber ML
  Improving Diagnosis in Health Care--The Next Imperative for Patient Safety. N Engl J Med. 2015 Dec 24;373(26):2493-5. doi: 10.1056/NEJMp1512241. Epub 2015 Nov 11. No abstract available.
•   Singh S, Loke YK, Enright PL, Furberg CD
  Mortality associated with tiotropium mist inhaler in patients with chronic obstructive pulmonary disease: systematic review and meta-analysis of randomised controlled trials. BMJ. 2011 Jun 14;342:d3215. doi: 10.1136/bmj.d3215.
•   Singh S, Loke YK, Furberg CD
  Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. JAMA. 2008 Sep 24;300(12):1439-50. doi: 10.1001/jama.300.12.1439. Erratum In: JAMA. 2009 Mar 25;301(12):1227-30.
•   Ski CF, King-Shier KM, Thompson DR
  Gender, socioeconomic and ethnic/racial disparities in cardiovascular disease: a time for change. Int J Cardiol. 2014 Jan 1;170(3):255-7. doi: 10.1016/j.ijcard.2013.10.082. Epub 2013 Nov 1.
•   Stange KC, Zyzanski SJ, Jaen CR, Callahan EJ, Kelly RB, Gillanders WR, Shank JC, Chao J, Medalie JH, Miller WL, Crabtree BF, Flocke SA, Gilchrist VJ, Langa DM, Goodwin MA
  Illuminating the 'black box'. A description of 4454 patient visits to 138 family physicians. J Fam Pract. 1998 May;46(5):377-89.
•   Tinkelman DG, Price DB, Nordyke RJ, Halbert RJ
  Misdiagnosis of COPD and asthma in primary care patients 40 years of age and over. J Asthma. 2006 Jan-Feb;43(1):75-80. doi: 10.1080/02770900500448738.
•   Van den Bruel A, Gailly J, Neyt M
  Does tiotropium lower exacerbation and hospitalization frequency in COPD patients: results of a meta-analysis. BMC Pulm Med. 2010 Sep 21;10:50. doi: 10.1186/1471-2466-10-50.
•   Walker PP, Mitchell P, Diamantea F, Warburton CJ, Davies L
  Effect of primary-care spirometry on the diagnosis and management of COPD. Eur Respir J. 2006 Nov;28(5):945-52. doi: 10.1183/09031936.06.00019306. Epub 2006 Jul 26.
•   Walters JA, Hansen E, Mudge P, Johns DP, Walters EH, Wood-Baker R
  Barriers to the use of spirometry in general practice. Aust Fam Physician. 2005 Mar;34(3):201-3.
•   Walters JA, Hansen EC, Johns DP, Blizzard EL, Walters EH, Wood-Baker R
  A mixed methods study to compare models of spirometry delivery in primary care for patients at risk of COPD. Thorax. 2008 May;63(5):408-14. doi: 10.1136/thx.2007.082859. Epub 2007 Nov 16.
•   Walters JA, Walters EH, Nelson M, Robinson A, Scott J, Turner P, Wood-Baker R
  Factors associated with misdiagnosis of COPD in primary care. Prim Care Respir J. 2011 Dec;20(4):396-402. doi: 10.4104/pcrj.2011.00039.
•   Wedzicha JA, Calverley PM, Seemungal TA, Hagan G, Ansari Z, Stockley RA; INSPIRE Investigators
  The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide. Am J Respir Crit Care Med. 2008 Jan 1;177(1):19-26. doi: 10.1164/rccm.200707-973OC. Epub 2007 Oct 4.
•   Yawn BP, Li Y, Tian H, Zhang J, Arcona S, Kahler KH
  Inhaled corticosteroid use in patients with chronic obstructive pulmonary disease and the risk of pneumonia: a retrospective claims data analysis. Int J Chron Obstruct Pulmon Dis. 2013;8:295-304. doi: 10.2147/COPD.S42366. Epub 2013 Jun 27.

Reducing Diagnostic Error to Improve Patient Safety in COPD and Asthma (REDEFINE Study)

Details for clinical trial NCT03137303